WeWork India, the leading flexible workspace provider, has secured SEBI's approval for its IPO, consisting entirely of an ...

Indian drugmaker Anthem Biosciences’ $395 million public listing was fully subscribed on the second day of bidding, as ...

Embassy-backed Wework receives SEBI nod for IPO debut with strong global brand partnerships and exclusive WeWork license in ...

Anthem Biosciences IPO opened for subscription on July 15, 2025, with a price band of Rs 540–570. The Rs 3,395 crore issue is entirely offer-for-sale (OFS) and will close on July 16.

WeWork India's IPO consists of 3.3 crore equity shares held by real estate company Embassy Group and 1.03 crore equity shares ...

New Delhi: The initial public offering (IPO) of Anthem Biosciences Ltd got fully subscribed on the day two of bidding on ...

India's markets regulator has given the green light to WeWork India's IPO. The IPO consists of equity shares from Embassy ...

Anthem Biosciences' Rs 3,395 crore IPO is fully subscribed on day 2. Details on subscription across investor categories and ...

Upcoming IPO: WeWork India Management Ltd, and Studds Accessories Ltd has been issued final observation by the Securities and ...

PhonePe, a Walmart-owned digital payments platform, has appointed former Meta India policy head Shivnath Thukral as vice president ahead of its anticipated IPO.

India's markets regulator has approved an initial public offering by WeWork India Management [WEWO.NS], the domestic franchisee of the U.S. shared office space manager, according to a regulatory ...

Late in March, the Securities and Exchange Board of India had temporarily put the draft papers in abeyance without specifying ...